Efficacy of lurasidone in adults aged 55 years and older with bipolar depression: Post Hoc analysis of 2 double-blind, placebo-controlled studies

Journal of Clinical Psychiatry

Volumn 77, Issue 10, 2016, Pages e1324-e1331

  Sajatovic, Martha ^a   Forester, Brent P ^b,c   Tsai, Joyce ^d   Kroger, Hans ^d   Pikalov, Andrei ^d   Cucchiaro, Josephine ^d   Loebel, Antony ^d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCLEAN HOSPITAL   (United States)

^d DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM CHLORIDE; LURASIDONE; PLACEBO; VALPROIC ACID; LITHIUM CARBONATE;

ABNORMAL DREAMING; ABNORMAL LABORATORY RESULT; ADJUVANT THERAPY; ADULT; AGED; AKATHISIA; ANXIETY DISORDER; BIPOLAR DEPRESSION; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DSM-IV-TR; FATIGUE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; MUSCLE SPASM; NAUSEA; POST HOC ANALYSIS; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; RHINOPHARYNGITIS; SIDE EFFECT; SOMNOLENCE; TREMOR; VOMITING; BIPOLAR DISORDER; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; MIDDLE AGED; PSYCHOLOGY;

AGED; BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM CARBONATE; LURASIDONE HYDROCHLORIDE; MALE; MIDDLE AGED; VALPROIC ACID;

EID: 84992731405     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m10261     Document Type: Conference Paper

References (32)

1. Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health. 2008;29(1):115-129. doi:10.146/anurev.publhealth.29.020907.090847 PubMed
2. Sajatovic M, Chen P. Geriatric bipolar disorder. Psychiatr Clin North Am. 2011;34(2):319-333. doi:10.1016/j.psc.201.02.07 PubMed
3. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59(6):530-537. doi:10.101/archpsyc.59.6.530 PubMed
4. Calabrese JR, Hirschfeld RM, Frye MA, et al. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a US community-based sample. J Clin Psychiatry. 2004;65(11):1499-1504. doi:10.408/JCP.v65n109 PubMed
5. Depp CA, Davis CE, Mittal D, et al. Health-related quality of life and functioning of middle-Aged and elderly adults with bipolar disorder. J Clin Psychiatry. 2006;67(2):215-221. doi:10.408/JCP.v67n0207 PubMed
6. Gildengers AG, Mulsant BH, Begley A, et al. The longitudinal course of cognition in older adults with bipolar disorder. Bipolar Disord. 2009;11(7):744-752. doi:10.1/j.139-5618.209.0739.x PubMed
7. Solomon DA, Leon AC, Coryell WH, et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry. 2010;67(4):339-347. doi:10.101/archgenpsychiatry.2010.15 PubMed
8. Fagiolini A, Forgione R, Maccari M, et al. Prevalence, chronicity, burden and borders of bipolar disorder. J Affect Disord. 2013;148(2-3):161-169. doi:10.1016/j.jad.2013.02.01 PubMed
9. Parker G, McCraw S, Hadzi-Pavlovic D, et al. Costs of the principal mood disorders: a study of comparative direct and indirect costs incurred by those with bipolar I, bipolar II and unipolar disorders. J Affect Disord. 2013;149(1-3):46-55. doi:10.1016/j.jad.2012.10.02 PubMed
10. Dols A, Kupka R, Kessing LV, et al. Bipolar disorder in the elderly. Aging Health. 2011;7(6):797-800. doi:10.217/ahe.1.75
11. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60(11):1079-1088. doi:10.101/archpsyc.60.1.1079 PubMed
12. Brown EB, McElroy SL, Keck PE Jr., et al. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry. 2006;67(7):1025-1033. doi:10.408/JCP.v67n0703 PubMed
13. Tohen M, McDonnell DP, Case M, et al. Randomised, double-blind, placebocontrolled study of olanzapine in patients with bipolar I depression. Br J Psychiatry. 2012;201(5):376-382. doi:10.192/bjp.bp.12.108357 PubMed
14. Sanford M, Keating GM. Quetiapine: a review of its use in the management of bipolar depression. CNS Drugs. 2012;26(5):435-460. doi:10.2165/1203840-0-0 PubMed
15. Loebel A, Cucchiaro J, Silva R, et al. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, doubleblind, placebo-controlled study. Am J Psychiatry. 2014;171(2):160-168. doi:10.176/api.ajp.2013.13070984 PubMed
16. Loebel A, Cucchiaro J, Silva R, et al. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry. 2014;171(2):169-177. doi:10.176/api.ajp.2013.13070985 PubMed
17. Ishibashi T, Horisawa T, Tokuda K, et al. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity. J Pharmacol Exp Ther. 2010;334(1):171-181. PubMed
18. Chiu YY, Ereshefsky L, Preskorn SH, et al. Lurasidone drug-drug interaction studies: a comprehensive review. Drug Metabol Drug Interact. 2014;29(3):191-202. doi:10.1515/dmdi-2014-05 PubMed
19. Loebel A, Xu J, Hsu J, et al. The development of lurasidone for bipolar depression. Ann N Y Acad Sci. 2015;1358:95-104. PubMed doi:10.1/nyas.12965
20. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33. PubMed
21. Sachs GS. Strategies for improving treatment of bipolar disorder: integration of measurement and management. Acta Psychiatr Scand suppl. 2004;110(422):7-17. doi:10.1/j.160-047.204.0409.x PubMed
22. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. doi:10.192/bjp.134.4.382 PubMed
23. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133(5):429-435. doi:10.192/bjp.13.5.429 PubMed
24. Spearing MK, Post RM, Leverich GS, et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73(3):159-171. doi:10.1016/S0165-1781(97)0123-6 PubMed
25. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583. doi:10.1016/S06-323(02)0186-8 PubMed
26. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-55. doi:10.1/j.204-8341.1959.tb0467.x PubMed
27. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321-326. PubMed
28. Sheehan DV. The Anxiety Disease. New York, NY: Bantam Books; 1983.
29. Chappell P, Feltner DE, Makumi C, et al. Initial validity and reliability data on the Columbia-Suicide Severity Rating Scale. Am J Psychiatry. 2012;169(6):662-663, author reply 663. doi:10.176/api.ajp.2012.12010123 PubMed
30. Cerullo MA, Strakowski SM. A systematic review of the evidence for the treatment of acute depression in bipolar I disorder. CNS Spectr. 2013;18(4):199-208. doi:10.1017/S10928529130102 PubMed
31. Selle V, Schalkwijk S, Vázquez GH, et al. Treatments for acute bipolar depression: meta-Analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics. Pharmacopsychiatry. 2014;47(2):43-52. doi:10.105/s-03-1363258 PubMed
32. Cooper C, Katona C, Lyketsos K, et al. A systematic review of treatments for refractory depression in older people. Am J Psychiatry. 2011;168(7):681-688. doi:10.176/api.ajp.201.108165 PubMed